Hindustan Antibiotics Limited (HAL), Pimpri, Pune, is the first public sector undertaking in the Drugs & Pharmaceutical Sector. The plant was commissioned in 1955-56. The undertaking with its plant at Pimpri, Pune is engaged in the manufacture of bulk drugs, mainly Penicillin, Streptomycin and a number of formulations.

There are three joint sector units promoted by HAL in collaboration with the respective State Governments. These are Karnataka Antibiotics & Pharmaceuticals Ltd. (KAPL), Bangalore (Karnataka), Maharashtra Antibiotics & Pharmaceuticals Ltd. (MAPL) at Nagpur (Maharashtra-since closed) and Manipur State Drugs & Pharmaceuticals Ltd. (MSDPL) at Imphal (Manipur-since closed). In addition there was a joint venture, namely, HMGB, with a private sector company Max GB-since discontinued.

Contact persons in H A L are the following:
Head Office:
Chief Executive's Office:
        Mr. T.K. Ranganathan
        Managing Director
        Tel    : 2773205 (Off), 2777410 (Res)

New Delhi Liason Office:
        First Floor, Core No. 6,
        Scope Complex,Lodhi Road,
        New Delhi - 110 003
        Tel/Fax   : 011-2436 4919
       

HAL has been incurring losses since 1993-94. The company was referred to the BIFR in January 1997. The BIFR declared the company as formally sick on 31.3.1997. The Government in March 2002 communicated to the BIFR that it is not in a position to submit a fully tied up proposal for rehabilitation of the company.

Government was, however, agreeable for change in management of the company and was willing to consider a financial restructuring package without infusion of additional funds alongwith and as part of disinvestment to a strategic partner.